Tag: chemistry
-
Ginkgo Acquires Biomaterials Maker as Industry Consolidates
A developer of synthetic biology tools and components is acquiring a biological materials developer for its automation assets as the biotechnology industry consolidates.
-
Trial Okayed for Engineered Cell Cancer Therapy
A clinical trial is set to begin testing engineered immune-system cells designed to precisely target and infiltrate cancerous tumors without other potentially toxic proteins.
-
Precision Protein Design Start-Up Gains $40M in Early Funds
A start-up company designing and testing precise proteins within live animals to speed creation of new therapeutics is raising $40 million in its first venture round.
-
Smell Detection Tech Company Raises $4M in Seed Funds
A start-up biotechnology company creating a system that translates an animal’s sense of smell into electronic signals is raising $4 million in seed equity funds.
-
Cancer Nutrition Therapy Biotech Raises $47M in Early Funds
A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round.
-
Diagnostics Companies Partner on Monkeypox Test
Two developers of tests for infectious diseases are collaborating on a molecular test to detect monkeypox, an emerging international public health concern.
-
Challenge Seeks Tech, Models to Reduce Stillbirths
A research competition is seeking better technologies to measure gestational development and predict outcomes to reduce the number of stillbirths by half.
-
GSK Acquires Advanced Vaccine Biotech in $3.3B Deal
Drug maker GSK is buying a biotechnology company developing vaccines for respiratory and infectious diseases that generate multiple immune responses.
-
AI Drug Company Creating Covid-19 Therapy for Rapid Delivery
A company applying artificial intelligence to drug discovery says it designed a new oral drug for Covid-19 infections that can be quickly produced.
-
Infographic – Synthetic Opioids Driving Overdose Deaths
While Covid-19 may grab health headlines in the U.S., the opioid epidemic is not going away, and shifting from prescription to synthetic compounds.